STOCK TITAN

Arxis, Inc. SEC Filings

ARXS NASDAQ

Welcome to our dedicated page for Arxis SEC filings (Ticker: ARXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Arxis, Inc. filings document material-event reporting for a newly public engineered-components manufacturer. The company's 8-K disclosures identify its completed initial public offering, Nasdaq-listed Class A common stock, Delaware corporate status, capital structure and related reorganization.

The filings also describe how the Arxis Businesses were placed under Arxis as wholly owned subsidiaries and record formal disclosure areas such as material definitive agreements, registered securities, governance matters and public-company reporting obligations.

Rhea-AI Summary

Arxis, Inc. reported record first quarter 2026 results with strong growth and improved profitability. Revenue reached $458.9 million, up 21% from the prior year, driven by strength in Defense & Space, Commercial Aerospace, and Industrial Technology. Net income was $53.3 million versus a loss of $4.3 million, giving an 11.6% net margin. Adjusted EBITDA rose to $175.2 million, up 31%, with margin expanding to 38.2%. Operating cash flow increased to $36.5 million and free cash flow to $24.8 million. The company completed an IPO in April 2026, raising about $1,221 million net and repaying approximately $946 million of Term Loan B debt. For full-year 2026, Arxis guides to revenue of $1,860–$1,880 million and Adjusted EBITDA of $720–$730 million, implying higher margins versus 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Arxis, Inc. reported strong Q1 2026 growth, with revenue of $458.9 million, up 20.7% from $380.1 million a year earlier, driven by both Electronic and Mechanical Components. Net income was $53.3 million, compared with a $4.3 million net loss in Q1 2025, as gross profit improved and interest expense fell.

Segment Adjusted EBITDA was $182.9 million, while company-reported Adjusted EBITDA was $175.2 million, or 38.2% of revenue, versus 35.3% a year ago, reflecting better operating leverage and cost control. Cash from operations rose to $36.5 million, funding capex of $11.7 million and helping support acquisitions.

Arxis continued its M&A strategy, acquiring Micro-Tronics for $71.6 million in January 2026. Debt stood at $2.68 billion at March 31, 2026. After quarter-end, the company completed an IPO that raised about $1.22 billion in net proceeds and used a significant portion to repay term-loan borrowings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Arxis, Inc. Chief Accounting Officer Ryan Anthony Jankowski reported two Class A Common Stock transactions connected to the company’s initial public offering. On April 16, he acquired 46,867 shares at $0.00 per share as an award of restricted stock that remains subject to time-vesting conditions, issued in replacement of equivalent equity interests in a subsidiary following the issuer’s reorganization for the IPO. On April 17, he made an open‑market purchase of 4,464 shares at $28.00 per share through the directed share program conducted in connection with the IPO. After these transactions, he directly owned 51,331 shares of Class A Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Allen Jennifer H. reported acquisition or exercise transactions in this Form 4 filing.

Arxis, Inc. reported that officer Jennifer H. Allen received an award of 53,695 shares of Class A Common Stock as restricted stock. The shares were granted at no cash cost and remain subject to time-based vesting conditions.

The filing explains that this restricted stock award replaces equity interests she previously held in a subsidiary of Arxis, following a reorganization connected to Arxis’s initial public offering. After this award, the filing shows Allen directly holding 53,695 Class A shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arxis, Inc. officer Badakhsh Azad Sid increased his direct stake in Class A Common Stock through an IPO-related equity award and a share purchase. He received an award covering 367,864 shares of restricted stock, of which 331,080 shares remain subject to time-vesting conditions.

He also made an open-market-style purchase of 36,000 Class A shares at $28.00 per share through the directed share program tied to the company’s initial public offering. Following these transactions, he directly holds a total of 403,864 Class A shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arxis, Inc. officer Ross Bradley Sealfon reported two transactions in Class A Common Stock. On April 16, 2026, he received 1,090,307 shares through a restricted stock award replacing equivalent equity interests in a subsidiary as part of the company’s initial public offering reorganization; 775,067 shares remain subject to time-vesting conditions.

On April 17, 2026, he made an open-market purchase of 12,500 shares at $28.00 per share through the IPO’s directed share program, bringing his direct holdings to 1,102,807 shares of Class A Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Arxis, Inc. director Stephen Duane Oetgen reported new investments in the company’s Class A Common Stock. He made an open-market purchase of 25,000 shares at $28.00 per share, and after this trade he directly holds 30,357 shares.

Separately, he received a grant of 5,357 restricted stock units, which will vest on the first anniversary of the grant date. The purchased shares were acquired through the directed share program conducted in connection with Arxis’s initial public offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arxis, Inc. director ALLEN PATRICK E increased his direct stake in the company. He made an open-market purchase of 10,000 shares of Class A Common Stock at $28.00 per share on April 17, 2026, bringing his direct holdings to 15,357 shares after the transaction.

He also received a grant of 5,357 restricted stock units, which will vest on the first anniversary of the grant date. The purchased shares were acquired through the directed share program conducted in connection with Arxis, Inc.'s initial public offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arxis, Inc. director and officer Kevin Scott Perhamus reported two equity acquisitions in Class A Common Stock. On April 16, 2026, he received a grant/award of 3,519,533 shares at $0.00 per share, reflecting equity issued in connection with Arxis’s initial public offering reorganization. This total includes shares of restricted stock, with 1,357,902 shares still subject to time-vesting conditions.

On April 17, 2026, he made an open-market purchase of 53,600 shares at $28.00 per share through the IPO directed share program. Following these transactions, he directly holds 3,573,133 shares of Arxis Class A Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Arxis, Inc. officer Jason Aaron Roth reported two recent transactions in Class A Common Stock. On April 17, 2026, he made an open-market purchase of 60,000 shares at $28.00 per share, bringing his direct holdings to 395,515 shares.

On April 16, 2026, he received a grant of 335,515 shares of Class A Common Stock at no cost, issued in connection with a reorganization tied to the company’s initial public offering. This grant includes 204,591 restricted shares that remain subject to time-vesting conditions. The 60,000 purchased shares were acquired through the directed share program associated with the IPO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Arxis (ARXS) SEC filings are available on StockTitan?

StockTitan tracks 15 SEC filings for Arxis (ARXS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Arxis (ARXS)?

The most recent SEC filing for Arxis (ARXS) was filed on May 28, 2026.